Acorn Bioventures has led a series B round for the cancer-focused biopharmaceutical spinout of CU Boulder.

AbbVie has bought an exclusive option to acquire Mitokinin once the UCSF spinout completes IND-enabling studies for its Parkinson’s treatment.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Osage University Partners has thrown its weight behind a series A2 round for Artizan, which is advancing work undertaken at Yale University.

Xenotransplantation technology developer eGenesis has raised $125m in a series C round backed by Osage University Partners.

Carisma Therapeutics has increased its series B round to $59m thanks to an extension backed by IP Group, Penn Medicine and 4Bio Capital.

RTW Investments has a series C for the UT Southwestern and Gladstone Institutes spinout, which will progress its lead asset into the clinic.

Judith Cone, the university’s vice-chancellor for innovation, entrepreneurship and economic development, has announced her intention to retire next month.

Jonathan Barada has joined IU Ventures as vice-president and his focus will include the firm’s Philanthropic Venture Fund.

The vehicle charging technology spinout of MIT has secured a further $18m for a Mitsubishi-backed round.